Immuron Ltd
NASDAQ:IMRN

Watchlist Manager
Immuron Ltd Logo
Immuron Ltd
NASDAQ:IMRN
Watchlist
Price: 0.885 USD 0.47% Market Closed
Market Cap: 5.3m USD

Wall Street
Price Targets

IMRN Price Targets Summary
Immuron Ltd

There are no price targets for IMRN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Immuron Ltd Competitors:
Price Targets
DTIL
Precision BioSciences Inc
684% Upside
DVYSR
Devyser Diagnostics AB
49% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
36% Upside
UTHR
United Therapeutics Corp
3% Upside
2256
Abbisko Cayman Ltd
79% Upside
688278
Xiamen Amoytop Biotech Co Ltd
22% Upside
RCKT
Rocket Pharmaceuticals Inc
131% Upside
300676
BGI Genomics Co Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Immuron Ltd

For the last 13 years the compound annual growth rate for Immuron Ltd's revenue is 24%. The projected CAGR for the next 7 years is -14%.

24%
Past Growth
-14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immuron Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Immuron Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMRN's stock price target?
Not Available

IMRN doesn't have any price targets made by Wall Street professionals.

What is Immuron Ltd's Revenue forecast?
Projected CAGR
-14%

For the last 13 years the compound annual growth rate for Immuron Ltd's revenue is 24%. The projected CAGR for the next 7 years is -14%.

Back to Top